IP Library Granted Patent US 10,371,700
Granted Patent B2
US 10,371,700 · App. 15/611,077 · Granted Aug 6, 2019

In-vitro diagnostic

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,371,700
App. No.
15/611,077
Granted
Aug 6, 2019
Kind
B2
Abstract

An in-vitro diagnostic includes a housing, a storage, and a blocking agent. The housing houses a liquid including a test substance included in a sample extracted from a subject. The storage stores a substance that specifically reacts with the test substance. The blocking agent is placed to separate the container and the storage.

Claims (9)

1. An in-vitro diagnostic comprising:

a housing for a liquid comprising a test substance contained in a sample extracted from a subject;

an optical waveguide as a support;

a substance layer, on the optical waveguide, that stores a substance that specifically reacts with the test substance and a first blocking agent that supports the substance, wherein the substance is bound to a surface of the optical waveguide; and

a dry film comprising a soluble coating agent and a second blocking agent separating the housing and the substance layer, wherein the dry film covers a surface of the substance layer, wherein the dry film does not contain a substance that specifically reacts with the test substance, and wherein the second blocking agent is different from the first blocking agent.

2. The in-vitro diagnostic according to claim 1 , wherein the second blocking agent is dispersed into a soluble coating agent included in the dry film.

3. The in-vitro diagnostic according to claim 1 , wherein the second blocking agent is covered by a lipid film and is dispersed into a soluble coating agent included in the dry film.

4. The in-vitro diagnostic according to claim 1 , wherein the second blocking agent is covered by a lipid film and is attached on an upper surface of the dry film.

5. The in-vitro diagnostic according to claim 1 , wherein the second blocking agent is selected in accordance with a measurement item.

Assignments (2)
CHANGE OF NAME Recorded Jun 25, 2019
From: TOSHIBA MEDICAL SYSTEMS CORPORATION
To: CANON MEDICAL SYSTEMS CORPORATION
Reel/Frame 049585/0954 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2017
From: HIRANO, ASUKA; KANAYAMA, SHOICHI; TONO, ICHIRO
To: TOSHIBA MEDICAL SYSTEMS CORPORATION
Reel/Frame 042564/0775 →